Anti-IRS1 (phospho S312) antibody [RP23040108]
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Multiclonal IRS1 phospho S312 antibody. Suitable for ICC/IF, WB and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Synthetic Peptide within Human IRS1 phospho S312.
View Alternative Names
Insulin receptor substrate 1, IRS-1, IRS1
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-IRS1 (phospho S312) antibody [RP23040108] (AB313437)
Immunofluorescent analysis of MCF7 cells treated with IGF (100 ng/mL/20 min) fixed using 4% formaldehyde (reconstituted in 1X PBS) for 10 min at room temperature and permeabilized using 0.1 % Triton X-100 in PBS for 15 min at room temperature labeling IRS with ab313437 at 1 ?g/mL followed by Goat anti-Rabbit IgG (H+L) Secondary Antibody, Alexa Fluor 488 conjugate at 1/2500 dilution. Panel a) shows representative cells that were stained for detection and localization of IRS (pS312) protein (green), Panel b) is stained for Nuclei (blue) using DAPI at 1/50 dilution. Panel c) represents cytoskeletal F-actin staining using Alexa Fluor 594 Phalloidin at 1/200 dilution. Panel d) is a composite image of Panels a, b and c clearly demonstrating nuclear localization of IRS (pS312). Panel e) represents cells without treatment and panel f) represents control cells with no primary antibody to assess background.
- WB
Supplier Data
Western blot - Anti-IRS1 (phospho S312) antibody [RP23040108] (AB313437)
All lanes:
Western blot - Anti-IRS1 (phospho S312) antibody [RP23040108] (ab313437) at 1 µg/mL
Lane 1:
HepG2 cell lysate at 30 µg
Lane 2:
HepG2 treated with IGF1 (100 ng/mL/20 min) cell lysate at 30 µg
Lane 3:
MCF7 cell lysate at 30 µg
Lane 4:
MCF7 treated with Insulin (100 nM/10 min) cell lysate at 30 µg
Lane 5:
C2C12 cell lysate at 30 µg
Lane 6:
C2C12 treated with Insulin (100 nM/ 10 minutes) cell lysate at 30 µg
Lane 7:
phosphopeptide incubated (10 µg/ml) HepG2 cell lysate at 30 µg
Lane 8:
phosphopeptide incubated (10 µg/ml) HepG2 treated with IGF1 (100 ng/mL/20 min) cell lysate at 30 µg
Lane 9:
phosphopeptide incubated (10 µg/ml) MCF7 cell lysate at 30 µg
Lane 10:
phosphopeptide incubated (10 µg/ml) MCF7 treated with Insulin (100 nM/10 min) cell lysate at 30 µg
Lane 11:
phosphopeptide incubated (10 µg/ml) C2C12 cell lysate at 30 µg
Lane 12:
phosphopeptide incubated (10 µg/ml) C2C12 treated with Insulin (100 nM/10 min) cell lysate at 30 µg
Secondary
All lanes:
Goat anti-Rabbit IgG (H+L) Secondary Antibody, HRP conjugate at 1/2500 dilution
Predicted band size: 131.591 kDa
Observed band size: 180 kDa
true
Reactivity data
Product details
What are recombinant multiclonals?
Recombinant multiclonals are a mixture of recombinant antibodies co-expressed from a library of heavy and light chains. They offer several advantages including:
- - The sensitivity of polyclonal antibodies by recognising multiple epitopes
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
View our range of recombinant multiclonal antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
IRS1 helps mediate the effects of insulin by acting as a downstream effector in the insulin signaling cascade. IRS1 functions in a complex manner binding with PI3K (phosphoinositide 3-kinase) after phosphorylation at specific tyrosine residues. This interaction is important for further signaling events leading to the regulation of glucose uptake lipid synthesis and gene expression. Besides its role in energy balance IRS1 plays a significant part in cell growth and differentiation driven by its ability to relay signals from the insulin and IGF receptors.
Pathways
IRS1 is heavily involved in the insulin signaling pathway and the PI3K-Akt pathway. Upon phosphorylation IRS1 binds to proteins such as the PI3K initiating a cascade that ultimately activates Akt resulting in anabolic processes within cells. The pathway is essential for regulating basic functions like metabolism growth and survival. IRS1's interaction with other related proteins like IR (insulin receptor) and IGFR (insulin-like growth factor receptor) highlights its integrative role in cellular processes related to energy and growth.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Diabetology & metabolic syndrome 17:374 PubMed41044623
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com